Please use this identifier to cite or link to this item: http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/16211
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAbramova, N.O.-
dc.date.accessioned2020-10-30T10:11:48Z-
dc.date.available2020-10-30T10:11:48Z-
dc.date.issued2019-
dc.identifier.urihttp://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/16211-
dc.description.abstractIntroduction. Diabetes mellitus is a metabolic disorder. About 4–5% of the world population suffers from diabetes. Obesity is considered as one of the strongest risk factors for type 2 diabetes manifestation. According to WHO, the prevalence of MS is 20-40%, thus receiving the characteristic of the "XXI century pandemia". The search for new ways of correction of carbohydrate metabolism is a promising direction. Objective.Improve treatment of carbohydrate metabolism disorders in patients with diabetes mellitus. Materials and methods. In order to determine the effect ofselenium-containing drugs on thyroid homeostasis indices in patients with diabetes mellitus type 2, we examined 65 patients who were randomized according to age and sex into two groups: 31 patients received basic therapy, 34 patients received selenium-containing ьувшсштуы in a dose equivalent to 50mcg of selenium per day against the background of standard treatment. Results.As a result of taking selenium on the background of basic treatment for 1 month, we have revealed an improvement in the state of carbohydrate metabolism comparing with control group - HOMA-IR (p <0,05). Conclusion. The obtained data suggestspositive effect of selenium containing medicines on background of standard treatment on carbohydrate metabolism by reduction of insulin resistance.uk_UA
dc.language.isoenuk_UA
dc.publisherSciences of Europe # 44, (2019). P.34-36.uk_UA
dc.subjectcarbohydrate metabolismuk_UA
dc.subjectmetabolic syndromeuk_UA
dc.subjecttype 2 diabetesuk_UA
dc.subjectseleniumuk_UA
dc.subjectуглеводный обменuk_UA
dc.subjectметаболический синдромuk_UA
dc.subjectдиабет 2 типаuk_UA
dc.subjectселенuk_UA
dc.subjectвуглеводний обмінuk_UA
dc.subjectметаболічний синдромuk_UA
dc.subjectдіабет 2 типуuk_UA
dc.titleINFLUENCE OF SELENIOUM-CONTAINING MEDICINES ON CARBOHYDRATE METABOLISM IN PATIENTS WITH DIABETES MELLITUSuk_UA
dc.typeArticleuk_UA
Appears in Collections:Статті. Кафедра клінічної імунології, алергології та ендокринології

Files in This Item:
File Description SizeFormat 
VOL 2, No 44 (2019).pdf625.22 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.